Full Name
BUYSE, Marc
Email
marc.buyse@uhasselt.be
 
Loading... 5 0 5 0 false
Loading... 6 0 5 0 false

Publications

Results 101-120 of 222 (Search time: 0.087 seconds).

Issue DateTitleContributor(s)TypeCat.
1012013Disease-Free Survival as a Surrogate for Overall Survival in Adjuvant Trials of Gastric Cancer: A Meta-AnalysisOba, Koji; PAOLETTI, Xavier; Alberts, Steven; Bang, Yung-Jue; Benedetti, Jacqueline; Bleiberg, Harry; CATALANO, Paul; Lordick, Florian; Michiels, Stefan; Morita, Satoshi; Ohashi, Yasuo; Pignon, Jean-pierre; Rougier, Philippe; Sasako, Mitsuru; Sakamoto, Junichi; Sargent, Daniel; Shitara, Kohei; Cutsem, Eric Van; BUYSE, Marc; BURZYKOWSKI, TomaszJournal ContributionA1
1022013Omics-based clinical trial designsBUYSE, Marc; Michiels, StefanJournal ContributionA1
1032013Prediction of survival benefits from progression-free survival benefits in advanced non-small-cell lung cancer: evidence from a meta-analysis of 2334 patients from 5 randomised trialsLaporte, Silvy; Squifflet, Pierre; Baroux, Noemie; Fossella, Frank; Georgoulias, Vassilis; Pujol, Jean-Louis; Douillard, Jean-Yves; Kudoh, Shinzohy; Pignon, Jean-Pierre; Quinaux, Emmanuel; BUYSE, MarcJournal ContributionA1
1042013Role of chemotherapy for advanced/recurrent gastric cancer: An individual-patient-data meta-analysisOba, Koji; PAOLETTI, Xavier; Bang, Yung-Jue; Bleiberg, Harry; BURZYKOWSKI, Tomasz; Fuse, Nozomu; Michiels, Stefan; Morita, Satoshi; Ohashi, Yasuo; Pignon, Jean-Pierre; Rougier, Philippe; Pompidou, Georges; Sakamoto, Junichi; Sargent, Daniel; Sasako, Mitsuru; Shitara, Kohei; Tsuburaya, Akira; Van Cutsem, Eric; BUYSE, MarcJournal ContributionA1
1052013Statistical evaluation of surrogate endpoints in clinical studiesMOLENBERGHS, Geert; ALONSO ABAD, Ariel; VAN DER ELST, Wim; BURZYKOWSKI, Tomasz; BUYSE, MarcBook SectionB2
1062013Review: Clinical Trial Methodology: Surrogate endpoints: when should they be used?MOLENBERGHS, Geert; ALONSO ABAD, Ariel; VAN DER ELST, Wim; BURZYKOWSKI, Tomasz; BUYSE, MarcJournal ContributionA1
1072012A statistical approach to central monitoring of data quality in clinical trialsVenet, David; Doffagne, Erik; BURZYKOWSKI, Tomasz; Beckers, Francois; Tellier, Yves; Genevois-Marlin, Eric; Becker, Ursula; Bee, Valerie; Wilson, Veronique; LEGRAND, Catherine; BUYSE, MarcJournal ContributionA1
1082012Predicting Treatment Effect from Surrogate Endpoints and Historical Trials: An Extrapolation Involving Probabilities of a Binary Outcome or Survival to a Specific TimeBaker, Stuart G.; Sargent, Daniel J.; BUYSE, Marc; BURZYKOWSKI, TomaszJournal ContributionA1
1092011Comparative assessment of trial-level surrogacy measures for candidate time-to-event surrogate endpoints in clinical trialsShi, Qian; Renfro, Lindsay A.; Bot, Brian M.; BURZYKOWSKI, Tomasz; BUYSE, Marc; Sargent, Daniel J.Journal ContributionA1
1102011Progression-free survival as a primary endpoint in clinical trials of metastatic colorectal cancerGill, S.; Berry, S.; Biagi, J.; Butts, C.; BUYSE, Marc; Chen, E.; Jonker, D.; Marginean, C.; Samson, B.; Stewart, J.; Thirlwell, M.; Wong, R.; Maroun, J. A.Journal ContributionA1
1112011Individual patient data meta-analysis of randomized trials evaluating IL-2 monotherapy as remission maintenance therapy in acute myeloid leukemiaBUYSE, Marc; Squifflet, Pierre; Lange, Beverly J.; Alonzo, Todd A.; Larson, Richard A.; Kolitz, Jonathan E.; George, Stephen L.; Bloomfield, Clara D.; Castaigne, Sylvie; Chevret, Sylvie; Blaise, Didier; Maraninchi, Dominique; Lucchesi, Kathryn J.; BURZYKOWSKI, TomaszJournal ContributionA1
1122011Multicenter Phase III Randomized Trial Comparing Docetaxel and Trastuzumab With Docetaxel, Carboplatin, and Trastuzumab As First-Line Chemotherapy for Patients With HER2-Gene-Amplified Metastatic Breast Cancer (BCIRG 007 Study): Two Highly Active Therapeutic RegimensValero, Vicente; Forbes, John; Pegram, Mark D.; Pienkowski, Tadeusz; Eiermann, Wolfgang; von Minckwitz, Gunter; Roche, Henri; Martin, Miguel; Crown, John; Mackey, John R.; Fumoleau, Pierre; Rolski, Janusz; Mrsic-Krmpotic, Zrinka; Jagiello-Gruszfeld, Agnieszka; Riva, Alessandro; BUYSE, Marc; Taupin, Henry; Sauter, Guido; Press, Michael F.; Slamon, Dennis J.Journal ContributionA1
1132011Assessment of the consistency and robustness of results from a multicenter trial of remission maintenance therapy for acute myeloid leukemiaBUYSE, Marc; Squifflet, Pierre; Lucchesi, Kathryn J.; Brune, Mats L.; Castaigne, Sylvie; Rowe, Jacob M.Journal ContributionA1
1142011Leukemia-free survival as a surrogate end point for overall survival in the evaluation of maintenance therapy for patients with acute myeloid leukemia in complete remissionBUYSE, Marc; Michiels, Stefan; Squifflet, Pierre; Lucchesi, Kathryn J.; Hellstrand, Kristoffer; Brune, Mats L.; Castaigne, Sylvie; Rowe, Jacob M.Journal ContributionA1
1152010Benefit of Adjuvant Chemotherapy for Resectable Gastric Cancer A Meta-analysisPAOLETTI, Xavier; Oba, Koji; BURZYKOWSKI, Tomasz; Michiels, Stefan; Ohashi, Yasuo; Pignon, Jean-Pierre; Rougier, Philippe; Sakamoto, Junichi; Sargent, Daniel; Sasako, Mitsuru; Van Cutsem, Eric; BUYSE, MarcJournal ContributionA1
1162010The correlation structure of longitudinal measurements of vision in patients with macular degeneration.BURZYKOWSKI, Tomasz; BUYSE, MarcJournal ContributionA1
1172010Generalized pairwise comparisons of prioritized outcomes in the two-sample problemBUYSE, MarcJournal ContributionA1
1182010A unified framework for the evaluation of surrogate endpoints in mental-health clinical trialsMOLENBERGHS, Geert; BURZYKOWSKI, Tomasz; ALONSO ABAD, Ariel; ASSAM NKOUIBERT, Pryseley; Tilahun, Abel; BUYSE, MarcJournal ContributionA1
1192009Radiological tumor size decrease at week 6 is a potent predictor of outcome in chemorefractory metastatic colorectal cancer treated with cetuximab (BOND trial)Piessevaux, H.; BUYSE, Marc; De Roock, W.; Prenen, H.; Schlichting, M.; Van Cutsem, E.; Tejpar, S.Journal ContributionA1
1202009Use of Meta-Analysis for the Validation of Surrogate Endpoints and Biomarkers in Cancer TrialsBUYSE, MarcJournal ContributionA1